arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

electroCore, Inc.

ECOR
$8.22 ▲ +1.65 (+25.11%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
38 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

electroCore, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap
Dividend Yield
Revenue Growth 42.6%
Op. Margin -55.5%
ROIC -241.6%
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -1.41
info Valuation on last close. End-of-day price, Aug 7, 2026.

38-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$9.58M
↑ +42.6%
Net Income Profit after all expenses
$-5.27M
↓ -36.7%
Operating Margin Operating profit as % of sales
-55.5%
↓ -74.3% 6th
FCF / Share Free cash flow per share
$-0.39
↑ +68.7%
Long-Term Debt Long-term obligations
$7.76M
— 0.0%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
7
Financial Health
52
Cash Quality
44

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 38 quarters